This is a double blind active placebo controlled clinical trial for individuals within an inpatient setting with moderate to severe depression. The purpose of this study is to assess if nebulized ketamine can reduce depressive symptoms.

Nebulized Ketamine for the Treatment of Major Depressive Disorder in an Inpatient Setting

Nebulized Ketamine for the Treatment of Major Depressive Disorder in an Inpatient Setting: A Midazolam-controlled Randomized Controlled Trial

The purpose of this research study is to develop and test an intervention designed to improve mood and reduce symptoms of depression.

Abbreviated MBCT for Depression in Older African American/Black Breast Cancer Survivors

Community Engagement in the Development of an Abbreviated Mindfulness-Based Cognitive Therapy Intervention for Depression in Older African American/Black Breast Cancer Survivors (Community Minds)

Treatment Trials

Filter & Search

Clinical Trial Results

Nebulized Ketamine for the Treatment of Major Depressive Disorder in an Inpatient Setting

Abbreviated MBCT for Depression in Older African American/Black Breast Cancer Survivors